Patel M, Pedreira C, De Oliveira LH, Tate J, Orozco M, Mercado J, et al. (June 2009). "Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua". JAMA. 301 (21): 2243–2251. doi:10.1001/jama.2009.756. PMID19491186.
Kramarz P, France EK, Destefano F, Black SB, Shinefield H, Ward JI, et al. (April 2001). "Population-based study of rotavirus vaccination and intussusception". The Pediatric Infectious Disease Journal. 20 (4): 410–416. doi:10.1097/00006454-200104000-00008. PMID11332666. S2CID23664999.
Matson DO (October 2006). "The pentavalent rotavirus vaccine, Rotateq". Seminars in Pediatric Infectious Diseases. 17 (4): 195–199. doi:10.1053/j.spid.2006.08.005. PMID17055370.
"Rotavirus Vaccine Live Oral". The American Society of Health-System Pharmacists. Archived from the original on 22 December 2015. Retrieved 14 December 2015.
"Rotavirus vaccines. WHO position paper – January 2013". Relevé Épidémiologique Hebdomadaire. 88 (5): 49–64. February 2013. hdl:10665/242024. PMID23424730.
World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. hdl:10665/371090. WHO/MHP/HPS/EML/2023.02.
World Health Organization (2014). "Global Advisory Committee on Vaccine Safety, 11-12 June 2014". Weekly Epidemiological Record. 89 (29): 321–36. hdl:10665/242243.
"Global Advisory Committee on Vaccine Safety, 11–12 December 2013". Relevé Épidémiologique Hebdomadaire. 89 (7): 53–60. February 2014. hdl:10665/242177. PMID24707510.
"Rotavirus vaccines. WHO position paper – January 2013". Relevé Épidémiologique Hebdomadaire. 88 (5): 49–64. February 2013. hdl:10665/242024. PMID23424730.
Patel M, Pedreira C, De Oliveira LH, Tate J, Orozco M, Mercado J, et al. (June 2009). "Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua". JAMA. 301 (21): 2243–2251. doi:10.1001/jama.2009.756. PMID19491186.
Kramarz P, France EK, Destefano F, Black SB, Shinefield H, Ward JI, et al. (April 2001). "Population-based study of rotavirus vaccination and intussusception". The Pediatric Infectious Disease Journal. 20 (4): 410–416. doi:10.1097/00006454-200104000-00008. PMID11332666. S2CID23664999.
Centers for Disease Control and Prevention (CDC) (September 2004). "Suspension of rotavirus vaccine after reports of intussusception--United States, 1999". MMWR. Morbidity and Mortality Weekly Report. 53 (34): 786–789. PMID15343145.
Matson DO (October 2006). "The pentavalent rotavirus vaccine, Rotateq". Seminars in Pediatric Infectious Diseases. 17 (4): 195–199. doi:10.1053/j.spid.2006.08.005. PMID17055370.
"Global Advisory Committee on Vaccine Safety, 11–12 December 2013". Relevé Épidémiologique Hebdomadaire. 89 (7): 53–60. February 2014. hdl:10665/242177. PMID24707510.
Kramarz P, France EK, Destefano F, Black SB, Shinefield H, Ward JI, et al. (April 2001). "Population-based study of rotavirus vaccination and intussusception". The Pediatric Infectious Disease Journal. 20 (4): 410–416. doi:10.1097/00006454-200104000-00008. PMID11332666. S2CID23664999.
"Rotavirus Vaccine Live Oral". The American Society of Health-System Pharmacists. Archived from the original on 22 December 2015. Retrieved 14 December 2015.
"ROTASIIL". WHO—Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control). 17 July 2020. Archived from the original on 27 July 2022. Retrieved 30 March 2021.
"ROTASIIL". WHO—Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control). 17 July 2020. Archived from the original on 27 July 2022. Retrieved 30 March 2021.